STOCK MARKET REPORT by CEO Silvano Grimaldi of the independent asset management company GRIMALDI & PARTNERS Ltd.
LAST MONTH REVIEW
The international stock markets ended November with losses.
- The fear of the coronavirus variant Omikron, newly discovered in southern Africa, is not only highly contagious due to an unusually large number of mutations, but could also penetrate the protective shield of the vaccines more easily.
- Persistently high inflation and the expectation of interest rate hikes in the coming year from the US Federal Reserve.
Particularly noticeable at STOCKS LEVEL:
Looking for SWISS LIFE shares with new financial targets
The group has set new financial targets for the next three years and has set the bar significantly higher than in the program that is coming to an end. Analysts welcome this.
Swiss Life has set "ambitious and beneficial" goals for the strategy period from 2022 to 2024, writes Georg Marti from the ZKB in a comment. The group is building on what has been achieved so far. In particular for the fee business, the requirement has been increased significantly.
After the small equity market correction in mid-November, the equity markets recovered and partially made up for the losses. The stock exchanges have already done well in the current year, mostly with double-digit price gains in the lower range. In this respect, no major jumps are to be expected for the month of December. A certain defensive stance on the part of investors should lead the stock market year to a calm end in December.
We expect a sideways trend in December.
© 2021, Grimaldi & Partners AG